MB "Profarmas" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
- |
0 |
0 |
0 |
2022 |
---|
0 |
0 |
0 |
0 |
0 |
- |
0.00 |
- |
- |
1 |
0 |
1 |
0 |
2023 |
---|
536,653 |
536,653 |
359,992 |
305,993 |
305,993 |
0.03 |
0.37 |
71.60 |
57.02 |
305,994 |
112,366 |
290,000 |
128,360 |
Register and
explore Okredo data2023 |
---|
536,653 |
536,653 |
359,992 |
305,993 |
305,993 |
0.03 |
0.37 |
71.60 |
57.02 |
305,994 |
112,366 |
290,000 |
128,360 |
Register and
explore Okredo data2023
Turnover (€)
536,653 €- *
Sales per employee (€)
536,653 €- *
Profit before tax (€)
359,992 €- *
Net Profit (€)
305,993 €- *
Profit per employee (€)
305,993 €- *
Working capital requirement
0.03 - *
Debt-to-equity ratio
0.37 - *
Total profitability (%)
71.60 %- *
Net profitability (%)
57.02 %- *
Equity (€)
305,994 €30,599,300 % *
Amounts Payable And Liabilities (€)
112,366 €- *
Non-current Assets (€)
290,000 €28,999,900 % *
CurrentAssets (€)
128,360 €- *